Abingdon Health (LON:ABDX) Hits New 12-Month High – What’s Next?

Abingdon Health Plc (LON:ABDX)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 13 and last traded at GBX 12.58, with a volume of 123163 shares. The stock had previously closed at GBX 12.25.

Abingdon Health Stock Performance

The company’s 50-day simple moving average is GBX 9.92 and its 200 day simple moving average is GBX 7.83. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The stock has a market cap of £31.57 million, a P/E ratio of -15.52 and a beta of 0.12.

Abingdon Health (LON:ABDX) last posted its earnings results on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.